Related references
Note: Only part of the references are listed.A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains
Mina Pastagia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Characterization of the staphylococcal bacteriophage lysin CHAPK
M. Fenton et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Structure of the γ-D-glutamyl-L-diamino acid endopeptidase YkfC from Bacillus cereus in complex with L-Ala-γ-D-Glu: insights into substrate recognition by NlpC/P60 cysteine peptidases
Qingping Xu et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2010)
Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus
Anu Daniel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
Michael Z. David et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Purified Recombinant Phage Lysin LySMP: An Extensive Spectrum of Lytic Activity for Swine Streptococci
Y. Wang et al.
CURRENT MICROBIOLOGY (2009)
LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells
Stephen C. Becker et al.
FEMS MICROBIOLOGY LETTERS (2009)
Bacterial complications during pandemic influenza infection
Tracy Hussell et al.
FUTURE MICROBIOLOGY (2009)
The Persistent Legacy of the 1918 Influenza Virus
David M. Morens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Min Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bacteriophage and their lysins for elimination of infectious bacteria
Sarah O'Flaherty et al.
FEMS MICROBIOLOGY REVIEWS (2009)
Bacteriophage lysins as effective antibacterials
Vincent A. Fischetti
CURRENT OPINION IN MICROBIOLOGY (2008)
Staphylococcus aureus bloodstream infections:: Risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006
Kevin B. Laupland et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Deaths from bacterial pneumonia during 1918-19 influenza pandemic
John F. Brundage et al.
EMERGING INFECTIOUS DISEASES (2008)
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005
Eili Klein et al.
EMERGING INFECTIOUS DISEASES (2007)
What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections
John F. Brundage et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φMR11
Mohammad Rashel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
PlyC: A multimeric bacteriophage lysin
Daniel Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The role of nasal carriage in Staphylococcus aureus infections
HFL Wertheim et al.
LANCET INFECTIOUS DISEASES (2005)
The global burden of group A streptococcal diseases
JR Carapetis et al.
LANCET INFECTIOUS DISEASES (2005)
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant Staphylococci, including methicillin-resistant Staphylococcus aureus
S O'Flaherty et al.
JOURNAL OF BACTERIOLOGY (2005)
Bacteriophage lytic enzymes: novel anti-infectives
VA Fischetti
TRENDS IN MICROBIOLOGY (2005)
In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus
MS Rouse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Community-acquired meticillin-resistant Staphylococcus aureus:: an emerging threat
N Zetola et al.
LANCET INFECTIOUS DISEASES (2005)
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles
LG Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage, lytic enzyme
Q Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002
EW Tiemersma et al.
EMERGING INFECTIOUS DISEASES (2004)
Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1
JA Hermoso et al.
STRUCTURE (2003)
Molecular basis of group A streptococcal virulence
AL Bisno et al.
LANCET INFECTIOUS DISEASES (2003)
Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus
K Sieradzki et al.
JOURNAL OF BACTERIOLOGY (2003)
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch et al.
NATURE (2002)
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase
JM Loeffler et al.
SCIENCE (2001)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
